Medeon Biodesign (Taiwan) Buy Hold or Sell Recommendation
6499 Stock | TWD 42.15 0.70 1.63% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Medeon Biodesign is 'Cautious Hold'. Macroaxis provides Medeon Biodesign buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding 6499 positions. The advice algorithm takes into account all of Medeon Biodesign's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Medeon Biodesign's buy or sell advice are summarized below:
Real Value 42.95 | Hype Value 42.15 | Market Value 42.15 | Naive Value 40.28 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Medeon Biodesign given historical horizon and risk tolerance towards Medeon Biodesign. When Macroaxis issues a 'buy' or 'sell' recommendation for Medeon Biodesign, the advice is generated through an automated system that utilizes algorithms and statistical models.
Medeon |
Execute Medeon Biodesign Buy or Sell Advice
The Medeon recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Medeon Biodesign. Macroaxis does not own or have any residual interests in Medeon Biodesign or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Medeon Biodesign's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
Cautious Hold
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Quite High | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Medeon Biodesign Trading Alerts and Improvement Suggestions
Medeon Biodesign generated a negative expected return over the last 90 days | |
Medeon Biodesign has high likelihood to experience some financial distress in the next 2 years | |
Medeon Biodesign generates negative cash flow from operations | |
About 50.0% of the company shares are owned by insiders or employees |
Medeon Biodesign Returns Distribution Density
The distribution of Medeon Biodesign's historical returns is an attempt to chart the uncertainty of Medeon Biodesign's future price movements. The chart of the probability distribution of Medeon Biodesign daily returns describes the distribution of returns around its average expected value. We use Medeon Biodesign price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Medeon Biodesign returns is essential to provide solid investment advice for Medeon Biodesign.
Mean Return | -0.11 | Value At Risk | -2.41 | Potential Upside | 2.10 | Standard Deviation | 1.86 |
Return Density |
Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Medeon Biodesign historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Medeon Biodesign Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Medeon Biodesign or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Medeon Biodesign's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Medeon stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.14 | |
β | Beta against NYSE Composite | 0.28 | |
σ | Overall volatility | 1.86 | |
Ir | Information ratio | -0.09 |
Medeon Biodesign Volatility Alert
Medeon Biodesign exhibits very low volatility with skewness of 3.11 and kurtosis of 15.93. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Medeon Biodesign's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Medeon Biodesign's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Medeon Biodesign Fundamentals Vs Peers
Comparing Medeon Biodesign's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Medeon Biodesign's direct or indirect competition across all of the common fundamentals between Medeon Biodesign and the related equities. This way, we can detect undervalued stocks with similar characteristics as Medeon Biodesign or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Medeon Biodesign's fundamental indicators could also be used in its relative valuation, which is a method of valuing Medeon Biodesign by comparing valuation metrics with those of similar companies.
Better Than Average | Worse Than Average | Compare Medeon Biodesign to competition |
Fundamentals | Medeon Biodesign | Peer Average |
Return On Equity | -0.1 | -0.31 |
Return On Asset | -0.0639 | -0.14 |
Profit Margin | (1.31) % | (1.27) % |
Operating Margin | (1.64) % | (5.51) % |
Current Valuation | 3.37 B | 16.62 B |
Shares Outstanding | 87.64 M | 571.82 M |
Shares Owned By Insiders | 50.07 % | 10.09 % |
Shares Owned By Institutions | 4.65 % | 39.21 % |
Price To Book | 1.29 X | 9.51 X |
Price To Sales | 19.67 X | 11.42 X |
Revenue | 68.96 M | 9.43 B |
Gross Profit | 28.63 M | 27.38 B |
EBITDA | (453.87 M) | 3.9 B |
Net Income | 2.08 B | 570.98 M |
Book Value Per Share | 43.26 X | 1.93 K |
Cash Flow From Operations | (293.38 M) | 971.22 M |
Earnings Per Share | 30.41 X | 3.12 X |
Number Of Employees | 16 | 18.84 K |
Beta | 0.79 | -0.15 |
Market Capitalization | 5 B | 19.03 B |
Total Asset | 4.36 B | 29.47 B |
Annual Yield | 0.02 % | |
Net Asset | 4.36 B | |
Last Dividend Paid | 0.83 |
Medeon Biodesign Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Medeon . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Medeon Biodesign Buy or Sell Advice
When is the right time to buy or sell Medeon Biodesign? Buying financial instruments such as Medeon Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Medeon Biodesign in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Construction Materials Thematic Idea Now
Construction Materials
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Construction Materials theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Construction Materials Theme or any other thematic opportunities.
View All Next | Launch |
Check out Medeon Biodesign Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Complementary Tools for Medeon Stock analysis
When running Medeon Biodesign's price analysis, check to measure Medeon Biodesign's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medeon Biodesign is operating at the current time. Most of Medeon Biodesign's value examination focuses on studying past and present price action to predict the probability of Medeon Biodesign's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medeon Biodesign's price. Additionally, you may evaluate how the addition of Medeon Biodesign to your portfolios can decrease your overall portfolio volatility.
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |